CTSL acts on the local microvasculature of high-grade serous carcinomas in an autocrine fashion to trigger the transcription and release of carbohydrate-binding protein galectin-1 (Gal 1), hence eliciting tumor angiogenesis (Pranjol et al., 2019). This evidence concerns the gene LGALS1 and neoplasm.